Quarterly report · Q2
2914.TEDINET S100RHVA
Period2023-01-01 → 2023-06-30
Filed2023-07-31
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.39T | 2023-01-01 → 2023-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥727.5bn | 2023-04-01 → 2023-06-30d | Cons. | Revenue IFRS |
| Revenue | ¥2.66T | 2022-01-01 → 2022-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.27T | 2022-01-01 → 2022-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥685.3bn | 2022-04-01 → 2022-06-30d | Cons. | Revenue IFRS |
| Operating income | ¥413.6bn | 2023-01-01 → 2023-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥207.2bn | 2023-04-01 → 2023-06-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥383.0bn | 2022-01-01 → 2022-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥204.6bn | 2022-04-01 → 2022-06-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥373.4bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥190.3bn | 2023-04-01 → 2023-06-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥593.5bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥361.0bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥186.3bn | 2022-04-01 → 2022-06-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥287.0bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥142.3bn | 2023-04-01 → 2023-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥442.7bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥264.1bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥140.0bn | 2022-04-01 → 2022-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥288.5bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥143.2bn | 2023-04-01 → 2023-06-30d | Cons. | Profit loss IFRS |
| Net income | ¥444.2bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥265.0bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥140.4bn | 2022-04-01 → 2022-06-30d | Cons. | Profit loss IFRS |
| Total assets | ¥6.97T | at 2023-06-30 | Cons. | Assets IFRS |
| Total assets | ¥6.55T | at 2022-12-31 | Cons. | Assets IFRS |
| Total assets | ¥6.65T | at 2022-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥3.02T | at 2023-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥2.93T | at 2022-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥3.95T | at 2023-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥3.62T | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥3.75T | at 2022-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.89T | at 2021-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥3.87T | at 2023-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥3.54T | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Cash & equivalents | ¥827.2bn | at 2023-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥866.9bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥748.7bn | at 2022-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥721.7bn | at 2021-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥206.9bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥483.8bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥110.2bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥102.7bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥101.8bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥38.8bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥163.3bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥306.2bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥158.2bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥161.7 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥80.18 | 2023-04-01 → 2023-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥249.45 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥148.8 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥78.86 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥161.65 | 2023-01-01 → 2023-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥80.16 | 2023-04-01 → 2023-06-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥249.36 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥148.74 | 2022-01-01 → 2022-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥78.83 | 2022-04-01 → 2022-06-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 55.5% | at 2023-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 54.1% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 55.3% | at 2022-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 136
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-01-01 → 2023-06-30 | ¥2.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-06-30 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-01-01 → 2023-06-30 | ¥711m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-06-30 | ¥268m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥783m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-06-30 | −¥20.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-06-30 | −¥20.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-06-30 | −¥18.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-06-30 | −¥10.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-06-30 | −¥10.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-06-30 | −¥8.1bn |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-06-30 | −¥1.6bn |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-06-30 | −¥881m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-06-30 | −¥1.6bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-06-30 | −¥881m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | ¥17m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | ¥17m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | ¥17m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | ¥9m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | ¥9m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | ¥9m |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥47.7bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥22.7bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥47.7bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥22.7bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥10.0bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥10.0bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥10.0bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥3.1bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥3.1bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥3.1bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥73.4bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥37.8bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥73.4bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥37.8bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥16m |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥8m |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥3.0bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥3.0bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥3.8bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥2.5bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥1.27T |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥666.8bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥1.27T |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥666.7bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥151m |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥90m |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥450.2bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥450.2bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥418.4bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥225.0bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥225.0bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥209.6bn |
| —segment total | revenue | 2023-01-01 → 2023-06-30 | ¥1.39T |
| —segment total | revenue | 2023-04-01 → 2023-06-30 | ¥727.4bn |
| —segment total | revenue external | 2023-01-01 → 2023-06-30 | ¥1.39T |
| —segment total | revenue external | 2023-04-01 → 2023-06-30 | ¥727.3bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥167m |
| —segment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥98m |
| —segment total | segment profit | 2023-01-01 → 2023-06-30 | ¥463.2bn |
| —segment total | segment profit | 2023-01-01 → 2023-06-30 | ¥463.2bn |
| —segment total | segment profit | 2023-01-01 → 2023-06-30 | ¥432.2bn |
| —segment total | segment profit | 2023-04-01 → 2023-06-30 | ¥229.7bn |
| —segment total | segment profit | 2023-04-01 → 2023-06-30 | ¥229.7bn |
| —segment total | segment profit | 2023-04-01 → 2023-06-30 | ¥215.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-01-01 → 2022-06-30 | ¥7.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-06-30 | ¥5.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-01-01 → 2022-06-30 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-06-30 | ¥496m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥6.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥5.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-06-30 | −¥16.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-06-30 | −¥16.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-06-30 | −¥12.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | −¥9.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | −¥9.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | −¥4.8bn |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-06-30 | −¥6.3bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥5.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-06-30 | −¥6.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥5.1bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | −¥47m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | −¥47m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | −¥47m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥10m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥10m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥10m |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥39.3bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥18.0bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥39.3bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥18.0bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥4.9bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥4.9bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥4.9bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥299m |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥299m |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥299m |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥73.5bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥37.8bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥73.5bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥37.8bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥416m |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥1.0bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥1.0bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥99m |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥1.15T |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥629.1bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥1.15T |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥629.0bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥138m |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥79m |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥425.1bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥425.1bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥390.3bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥227.8bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥227.8bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥209.0bn |
| —segment total | revenue | 2022-01-01 → 2022-06-30 | ¥1.27T |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥684.9bn |
| —segment total | revenue external | 2022-01-01 → 2022-06-30 | ¥1.27T |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥684.8bn |
| —segment total | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥138m |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥79m |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | ¥431.4bn |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | ¥431.4bn |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | ¥395.6bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥229.1bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥229.1bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥209.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,138
| Item | Context | Value | Unit |
|---|---|---|---|
| Cash flows from used in financing activities IFRS (5-year summary) | Prior1YearDuration | -306176000000 | JPY |
| Cash and cash equivalents IFRS (5-year summary) | Prior1QuarterInstant | 748696000000 | JPY |
| Cash and cash equivalents IFRS (5-year summary) | CurrentQuarterInstant | 827220000000 | JPY |
| Cash and cash equivalents IFRS (5-year summary) | Prior1YearInstant | 866885000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 2000000000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 2000000000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 2000000000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 2000000000 | |
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 666925200 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.3757 | |
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 185009600 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.1042 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 67969100 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0383 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 41507746 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0234 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 24399741 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0137 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 18627200 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0105 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 18088600 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0102 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 12317033 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0069 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 11633269 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0066 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 11392654 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0064 | |
| Number of shares held | CurrentQuarterInstant | 1057870143 | |
| Shareholding ratio | CurrentQuarterInstant | 0.5960 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 224934300 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 1773827300 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 17738273 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 1238400 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 2000000000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 17738273 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 224934300 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 224934300 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.1125 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 224934300 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 224934300 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.1125 | |
| Cash and cash equivalents IFRS | Prior1YearInstant | 866885000000 | JPY |
| Cash and cash equivalents IFRS | CurrentQuarterInstant | 827220000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |